[Federal Register: November 16, 2007 (Volume 72, Number 221)]
[Notices]               
[Page 64681]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr16no07-147]                         

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

 
Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated June 26, 2007, and published in the Federal 
Register on July 3, 2007, (72 FR 36482), Johnson Matthey Inc., Custom 
Pharmaceuticals Department, 2003 Nolte Drive, West Deptford, New Jersey 
08066-1742, made application by letter to the Drug Enforcement 
Administration (DEA) to be registered as a bulk manufacturer of the 
basic classes of controlled substances listed in schedule II:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Cocaine (9041).............................  II
Ecgonine (9180)............................  II
------------------------------------------------------------------------

    The company plans on producing cocaine for sale to its customers, 
who are final dosage manufacturers. The ecgonine is formed during the 
manufacturing process for cocaine.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and determined that the registration of 
Johnson Matthey Inc. to manufacture the listed basic class of 
controlled substance is consistent with the public interest at this 
time. DEA has investigated Johnson Matthey Inc. to ensure that the 
company's registration is consistent with the public interest. The 
investigation has included inspection and testing of the company's 
physical security systems, verification of the company's compliance 
with state and local laws, and a review of the company's background and 
history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 
21 CFR 1301.33, the above named company is granted registration as a 
bulk manufacturer of the basic classes of controlled substances listed.

    Dated: November 6, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
 [FR Doc. E7-22478 Filed 11-15-07; 8:45 am]

BILLING CODE 4410-09-P